USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	066179/0074			Pages:	152
		Recorded:	01/02/2024
Attorney Dkt #:	324998.130
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 197
Page 1 of 2
Pages: 1 2

1

Patent #:	10138462	Issue Dt:	11/27/2018	Application #:	10008955	Filing Dt:	12/07/2001
Publication #:	US20020068044	Pub Dt:	06/06/2002
Title:	Natural killer cell lines and methods of use

2

Patent #:	8492118	Issue Dt:	07/23/2013	Application #:	12151980	Filing Dt:	05/09/2008
Publication #:	US20090324538	Pub Dt:	12/31/2009
Title:	FUSION MOLECULES AND IL-15 VARIANTS

3

Patent #:	8298549	Issue Dt:	10/30/2012	Application #:	12651836	Filing Dt:	01/04/2010
Publication #:	US20100183673	Pub Dt:	07/22/2010
Title:	SEQUENTIAL ADMINISTRATION OF A REPLICATION DEFECTIVE ADENOVIRUS VECTOR IN VACCINATION PROTOCOLS

4

Patent #:	8163879	Issue Dt:	04/24/2012	Application #:	12700949	Filing Dt:	02/05/2010
Publication #:	US20100278774	Pub Dt:	11/04/2010
Title:	FUSION MOLECULES AND IL-15 VARIANTS

5

Patent #:	8933198	Issue Dt:	01/13/2015	Application #:	12731485	Filing Dt:	03/25/2010
Publication #:	US20100303829	Pub Dt:	12/02/2010
Title:	HIV VPR-SPECIFIC T CELL RECEPTORS

6

Patent #:	9416165	Issue Dt:	08/16/2016	Application #:	12739639	Filing Dt:	04/23/2010
Publication #:	US20100247521	Pub Dt:	09/30/2010
Title:	METHODS OF INHIBITING VIRAL REPLICATION AND IMPROVING T CELL FUNCTION EMPLOYING SOLUBLE TIM-3 INHIBITORS.

7

Patent #:	8507222	Issue Dt:	08/13/2013	Application #:	13238925	Filing Dt:	09/21/2011
Publication #:	US20120177595	Pub Dt:	07/12/2012
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

8

Patent #:	8940289	Issue Dt:	01/27/2015	Application #:	13428776	Filing Dt:	03/23/2012
Publication #:	US20120230946	Pub Dt:	09/13/2012
Title:	FUSION MOLECULES AND IL-15 VARIANTS

9

Patent #:	11344613	Issue Dt:	05/31/2022	Application #:	13622263	Filing Dt:	09/18/2012
Publication #:	US20130224144	Pub Dt:	08/29/2013
Title:	SEQUENTIAL ADMINISTRATION OF A REPLICATION DEFECTIVE ADENOVIRUS VECTOR IN VACCINATION PROTOCOLS

10

Patent #:	9255141	Issue Dt:	02/09/2016	Application #:	13769179	Filing Dt:	02/15/2013
Publication #:	US20140242025	Pub Dt:	08/28/2014
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF TREATING NEOPLASIA AND HIV USING SAME

11

Patent #:	9328159	Issue Dt:	05/03/2016	Application #:	13854903	Filing Dt:	04/01/2013
Publication #:	US20140134128	Pub Dt:	05/15/2014
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

12

Patent #:	9428573	Issue Dt:	08/30/2016	Application #:	13946313	Filing Dt:	07/19/2013
Publication #:	US20140205560	Pub Dt:	07/24/2014
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

13

Patent #:	9464127	Issue Dt:	10/11/2016	Application #:	13946438	Filing Dt:	07/19/2013
Publication #:	US20140219955	Pub Dt:	08/07/2014
Title:	FUSION MOLECULES AND IL-15 VARIANTS

14

Patent #:	9605276	Issue Dt:	03/28/2017	Application #:	14422504	Filing Dt:	02/19/2015
Publication #:	US20160076053	Pub Dt:	03/17/2016
Title:	REPLICATION DEFECTIVE ADENOVIRUS VECTOR IN VACCINATION

15

Patent #:	9714279	Issue Dt:	07/25/2017	Application #:	14560314	Filing Dt:	12/04/2014
Publication #:	US20150087059	Pub Dt:	03/26/2015
Title:	HIV VPR-SPECIFIC T-CELL RECEPTORS

16

Patent #:	9593152	Issue Dt:	03/14/2017	Application #:	14568573	Filing Dt:	12/12/2014
Publication #:	US20150132257	Pub Dt:	05/14/2015
Title:	METHODS OF TREATING DISEASE WITH FUSION MOLECULES COMPRISING IL-15 VARIANTS

17

Patent #:	9925247	Issue Dt:	03/27/2018	Application #:	14755989	Filing Dt:	06/30/2015
Publication #:	US20150374790	Pub Dt:	12/31/2015
Title:	IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

18

Patent #:	10258649	Issue Dt:	04/16/2019	Application #:	15032518	Filing Dt:	04/27/2016
Publication #:	US20160250256	Pub Dt:	09/01/2016
Title:	TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

19

Patent #:	10150805	Issue Dt:	12/11/2018	Application #:	15083998	Filing Dt:	03/29/2016
Publication #:	US20160213750	Pub Dt:	07/28/2016
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

20

Patent #:	11261231	Issue Dt:	03/01/2022	Application #:	15208924	Filing Dt:	07/13/2016
Publication #:	US20160311890	Pub Dt:	10/27/2016
Title:	METHODS FOR INHIBITING HIV OR HCV INFECTION BY ADMINISTERING TIM-3 BINDING INHIBITORS

21

Patent #:	10358478	Issue Dt:	07/23/2019	Application #:	15213991	Filing Dt:	07/19/2016
Publication #:	US20160355567	Pub Dt:	12/08/2016
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

22

Patent #:	10450359	Issue Dt:	10/22/2019	Application #:	15254713	Filing Dt:	09/01/2016
Publication #:	US20160367635	Pub Dt:	12/22/2016
Title:	IL-15 VARIANTS AND USES THEREOF

23

Patent #:	11376316	Issue Dt:	07/05/2022	Application #:	15265709	Filing Dt:	09/14/2016
Publication #:	US20170065693	Pub Dt:	03/09/2017
Title:	BREAST CANCER VACCINES AND METHODS OF USE THEREOF

24

Patent #:	11369673	Issue Dt:	06/28/2022	Application #:	15265723	Filing Dt:	09/14/2016
Publication #:	US20170065706	Pub Dt:	03/09/2017
Title:	HPV VACCINES AND METHODS OF USE THEREOF

25

Patent #:	10563224	Issue Dt:	02/18/2020	Application #:	15433934	Filing Dt:	02/15/2017
Publication #:	US20170165341	Pub Dt:	06/15/2017
Title:	REPLICATION DEFECTIVE ADENOVIRUS VECTOR IN VACCINATION

26

Patent #:	11154597	Issue Dt:	10/26/2021	Application #:	15468046	Filing Dt:	03/23/2017
Publication #:	US20170312351	Pub Dt:	11/02/2017
Title:	SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION

27

Patent #:	10456420	Issue Dt:	10/29/2019	Application #:	15529848	Filing Dt:	05/25/2017
Publication #:	US20180193383	Pub Dt:	07/12/2018
Title:	GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER

28

Patent #:	10738279	Issue Dt:	08/11/2020	Application #:	15531109	Filing Dt:	05/26/2017
Publication #:	US20180163176	Pub Dt:	06/14/2018
Title:	MODIFIED NK-92 CELLS FOR TREATING CANCER

29

Patent #:	10695417	Issue Dt:	06/30/2020	Application #:	15542003	Filing Dt:	07/06/2017
Publication #:	US20170368161	Pub Dt:	12/28/2017
Title:	HUMAN ADENOVIRUS SEROTYPE 5 VECTORS CONTAINING E1 AND E2B DELETIONS ENCODING THE EBOLAVIRUS GLYCOPROTEIN

30

Patent #:	11352642	Issue Dt:	06/07/2022	Application #:	15542005	Filing Dt:	07/06/2017
Publication #:	US20180187211	Pub Dt:	07/05/2018
Title:	METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY

31

Patent #:	11149087	Issue Dt:	10/19/2021	Application #:	15564413	Filing Dt:	10/04/2017
Publication #:	US20180344832	Pub Dt:	12/06/2018
Title:	METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY

32

Patent #:	10865230	Issue Dt:	12/15/2020	Application #:	15606552	Filing Dt:	05/26/2017
Publication #:	US20170342119	Pub Dt:	11/30/2017
Title:	CONSTRUCTION AND CHARACTERIZATION OF MULTIMERIC IL-15-BASED MOLECULES WITH CD3 BINDING DOMAINS

33

Patent #:	10844107	Issue Dt:	11/24/2020	Application #:	15659612	Filing Dt:	07/25/2017
Publication #:	US20180148493	Pub Dt:	05/31/2018
Title:	HIV VPR-SPECIFIC T-CELL RECEPTORS

34

Patent #:	10801005	Issue Dt:	10/13/2020	Application #:	15703500	Filing Dt:	09/13/2017
Publication #:	US20180072981	Pub Dt:	03/15/2018
Title:	SYSTEMS, APPARATUS AND METHODS FOR CONTROLLING A MOVEMENT OF A CELL CULTURE TO OPTIMIZE CELL GROWTH

35

Patent #:	11129883	Issue Dt:	09/28/2021	Application #:	15913837	Filing Dt:	03/06/2018
Publication #:	US20190046623	Pub Dt:	02/14/2019
Title:	IL-15-BASED FUSIONS TO IL-12 AND IL-18

36

Patent #:	10801013	Issue Dt:	10/13/2020	Application #:	15914665	Filing Dt:	03/07/2018
Publication #:	US20180258397	Pub Dt:	09/13/2018
Title:	MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC

37

Patent #:	10537615	Issue Dt:	01/21/2020	Application #:	15921512	Filing Dt:	03/14/2018
Publication #:	US20190022187	Pub Dt:	01/24/2019
Title:	IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

38

Patent #:	10899821	Issue Dt:	01/26/2021	Application #:	15951042	Filing Dt:	04/11/2018
Publication #:	US20190023766	Pub Dt:	01/24/2019
Title:	METHOD OF TREATING NEOPLASIA WITH A MULTIMERIC IL-15 SOLUBLE FUSION MOLECULE

39

Patent #:	10973852	Issue Dt:	04/13/2021	Application #:	16071860	Filing Dt:	07/20/2018
Publication #:	US20190083533	Pub Dt:	03/21/2019
Title:	NK Cells with Altered CXCL12/CXCR4 Signaling

40

Patent #:	11585805	Issue Dt:	02/21/2023	Application #:	16076280	Filing Dt:	08/07/2018
Publication #:	US20210223231	Pub Dt:	07/22/2021
Title:	Methods of Immunogenic Modulation

41

Patent #:	11161890	Issue Dt:	11/02/2021	Application #:	16114870	Filing Dt:	08/28/2018
Publication #:	US20190300591	Pub Dt:	10/03/2019
Title:	IL-15-BASED FUSIONS TO IL-7 AND IL-21

42

Patent #:	10646516	Issue Dt:	05/12/2020	Application #:	16212578	Filing Dt:	12/06/2018
Publication #:	US20190125801	Pub Dt:	05/02/2019
Title:	TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

43

Patent #:	10517895	Issue Dt:	12/31/2019	Application #:	16289494	Filing Dt:	02/28/2019
Publication #:	US20190192568	Pub Dt:	06/27/2019
Title:	TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

44

Patent #:	10772912	Issue Dt:	09/15/2020	Application #:	16289512	Filing Dt:	02/28/2019
Publication #:	US20190192569	Pub Dt:	06/27/2019
Title:	A TUMORICIDAL AND ANTIMICROBIAL COMPOSITION

45

Patent #:	11213547	Issue Dt:	01/04/2022	Application #:	16289526	Filing Dt:	02/28/2019
Publication #:	US20190192570	Pub Dt:	06/27/2019
Title:	TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

46

Patent #:	11207392	Issue Dt:	12/28/2021	Application #:	16312246	Filing Dt:	12/20/2018
Publication #:	US20190381156	Pub Dt:	12/19/2019
Title:	Coordinated Multi-Prong Cancer Therapy

47

Patent #:	10835596	Issue Dt:	11/17/2020	Application #:	16317739	Filing Dt:	01/14/2019
Publication #:	US20200171140	Pub Dt:	06/04/2020
Title:	COMPOSITIONS AND METHODS FOR FLAVIVIRUS VACCINATION

48

Patent #:	11104916	Issue Dt:	08/31/2021	Application #:	16317747	Filing Dt:	01/14/2019
Publication #:	US20200172925	Pub Dt:	06/04/2020
Title:	COMPOSITIONS AND METHODS FOR ALPHAVIRUS VACCINATION

49

Patent #:	NONE	Issue Dt:		Application #:	16317766	Filing Dt:	01/14/2019
Publication #:	US20190290646	Pub Dt:	09/26/2019
Title:	HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES

50

Patent #:	11168138	Issue Dt:	11/09/2021	Application #:	16365587	Filing Dt:	03/26/2019
Publication #:	US20200002425	Pub Dt:	01/02/2020
Title:	ANTI-PDL1, IL-15 AND TGF-BETA RECEPTOR COMBINATION MOLECULES

51

Patent #:	11590217	Issue Dt:	02/28/2023	Application #:	16390946	Filing Dt:	04/22/2019
Publication #:	US20200016254	Pub Dt:	01/16/2020
Title:	Neoepitope vaccine and minnune stimulant combinations and methods

52

Patent #:	10774310	Issue Dt:	09/15/2020	Application #:	16424201	Filing Dt:	05/28/2019
Publication #:	US20190300854	Pub Dt:	10/03/2019
Title:	MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC

53

Patent #:	11053299	Issue Dt:	07/06/2021	Application #:	16442265	Filing Dt:	06/14/2019
Publication #:	US20190330309	Pub Dt:	10/31/2019
Title:	SUPERKINE

54

Patent #:	11311603	Issue Dt:	04/26/2022	Application #:	16443560	Filing Dt:	06/17/2019
Publication #:	US20190381141	Pub Dt:	12/19/2019
Title:	HIV TREATMENT COMPOSITIONS AND METHODS

55

Patent #:	11173191	Issue Dt:	11/16/2021	Application #:	16444807	Filing Dt:	06/18/2019
Publication #:	US20200016239	Pub Dt:	01/16/2020
Title:	IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

56

Patent #:	NONE	Issue Dt:		Application #:	16475926	Filing Dt:	07/03/2019
Publication #:	US20200123503	Pub Dt:	04/23/2020
Title:	GENETICALLY MODIFIED NK-92 CELLS WITH DECREASED CD96/TIGIT EXPRESSION

57

Patent #:	11229668	Issue Dt:	01/25/2022	Application #:	16483978	Filing Dt:	08/06/2019
Publication #:	US20200023008	Pub Dt:	01/23/2020
Title:	MAXIMIZING T-CELL MEMORY AND COMPOSITIONS AND METHODS THEREFOR

58

Patent #:	11221328	Issue Dt:	01/11/2022	Application #:	16491559	Filing Dt:	09/05/2019
Publication #:	US20200041490	Pub Dt:	02/06/2020
Title:	HYPOXIC NK CELLS AND METHODS THEREFOR

59

Patent #:	11453862	Issue Dt:	09/27/2022	Application #:	16505528	Filing Dt:	07/08/2019
Publication #:	US20210009953	Pub Dt:	01/14/2021
Title:	Mononuclear Cell Derived NK Cells

60

Patent #:	10960024	Issue Dt:	03/30/2021	Application #:	16529029	Filing Dt:	08/01/2019
Publication #:	US20200038441	Pub Dt:	02/06/2020
Title:	QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES

61

Patent #:	11077143	Issue Dt:	08/03/2021	Application #:	16529159	Filing Dt:	08/01/2019
Publication #:	US20200129552	Pub Dt:	04/30/2020
Title:	ELIMINATION OF PD-L1-POSITIVE MALIGNANCIES BY PD-L1 CHIMERIC ANTIGEN RECEPTOR-EXPRESSING NK CELLS

62

Patent #:	10765701	Issue Dt:	09/08/2020	Application #:	16529251	Filing Dt:	08/01/2019
Publication #:	US20200129553	Pub Dt:	04/30/2020
Title:	ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS

63

Patent #:	10736921	Issue Dt:	08/11/2020	Application #:	16541847	Filing Dt:	08/15/2019
Publication #:	US20190365816	Pub Dt:	12/05/2019
Title:	GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER

64

Patent #:	11894109	Issue Dt:	02/06/2024	Application #:	16561773	Filing Dt:	09/05/2019
Title:	Production And Delivery Tracking And Sample Verification Of Patient-Specific Therapeutics

65

Patent #:	NONE	Issue Dt:		Application #:	16576415	Filing Dt:	09/19/2019
Publication #:	US20200096511	Pub Dt:	03/26/2020
Title:	SAMPLE DESTRUCTION VALIDATION SYSTEM AND METHODS

66

Patent #:	11304977	Issue Dt:	04/19/2022	Application #:	16598418	Filing Dt:	10/10/2019
Publication #:	US20200038445	Pub Dt:	02/06/2020
Title:	TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

67

Patent #:	11779637	Issue Dt:	10/10/2023	Application #:	16606993	Filing Dt:	10/21/2019
Publication #:	US20200054730	Pub Dt:	02/20/2020
Title:	TARGETED NEOEPITOPE VECTORS AND METHODS THEREFOR

68

Patent #:	11020467	Issue Dt:	06/01/2021	Application #:	16614909	Filing Dt:	11/19/2019
Publication #:	US20200155662	Pub Dt:	05/21/2020
Title:	COMBINATION IMMUNOTHERAPIES COMPRISING IL-15 SUPERAGONISTS

69

Patent #:	11116827	Issue Dt:	09/14/2021	Application #:	16615925	Filing Dt:	11/22/2019
Publication #:	US20200147193	Pub Dt:	05/14/2020
Title:	COMPOSITIONS AND METHODS FOR TUMOR VACCINATION AND IMMUNOTHERAPY INVOLVING HER ANTIGENS

70

Patent #:	11510982	Issue Dt:	11/29/2022	Application #:	16639526	Filing Dt:	02/14/2020
Publication #:	US20200237908	Pub Dt:	07/30/2020
Title:	haNK CETUXIMAB COMBINATIONS AND METHODS

71

Patent #:	11365231	Issue Dt:	06/21/2022	Application #:	16654958	Filing Dt:	10/16/2019
Publication #:	US20200140513	Pub Dt:	05/07/2020
Title:	INTERLEUKIN 15 (IL-15) VARIANTS

72

Patent #:	11564980	Issue Dt:	01/31/2023	Application #:	16656293	Filing Dt:	10/17/2019
Publication #:	US20200046817	Pub Dt:	02/13/2020
Title:	TUMOR TREATMENT METHOD WITH AN INDIVIDUALIZED PEPTIDE VACCINE

73

Patent #:	11498950	Issue Dt:	11/15/2022	Application #:	16659311	Filing Dt:	10/21/2019
Title:	FUSION MOLECULES AND IL-15 VARIANTS

74

Patent #:	11129850	Issue Dt:	09/28/2021	Application #:	16707807	Filing Dt:	12/09/2019
Publication #:	US20200101111	Pub Dt:	04/02/2020
Title:	QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES

75

Patent #:	11058723	Issue Dt:	07/13/2021	Application #:	16708082	Filing Dt:	12/09/2019
Publication #:	US20200093863	Pub Dt:	03/26/2020
Title:	QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES

76

Patent #:	11046747	Issue Dt:	06/29/2021	Application #:	16749955	Filing Dt:	01/22/2020
Publication #:	US20200190164	Pub Dt:	06/18/2020
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

77

Patent #:	11104716	Issue Dt:	08/31/2021	Application #:	16749967	Filing Dt:	01/22/2020
Publication #:	US20200181237	Pub Dt:	06/11/2020
Title:	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

78

Patent #:	11369679	Issue Dt:	06/28/2022	Application #:	16752606	Filing Dt:	01/24/2020
Publication #:	US20200261575	Pub Dt:	08/20/2020
Title:	MULTIMERIC IL-15-BASED MOLECULES

79

Patent #:	NONE	Issue Dt:		Application #:	16760893	Filing Dt:	04/30/2020
Publication #:	US20210187024	Pub Dt:	06/24/2021
Title:	NK-92 Cells to Stimulate Anti-Cancer Vaccine

80

Patent #:	11230699	Issue Dt:	01/25/2022	Application #:	16775111	Filing Dt:	01/28/2020
Publication #:	US20210230547	Pub Dt:	07/29/2021
Title:	CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER-FAMILY RECEPTORS

81

Patent #:	11071774	Issue Dt:	07/27/2021	Application #:	16783734	Filing Dt:	02/06/2020
Publication #:	US20200171137	Pub Dt:	06/04/2020
Title:	NANT CANCER VACCINE

82

Patent #:	NONE	Issue Dt:		Application #:	16796226	Filing Dt:	02/20/2020
Publication #:	US20210009954	Pub Dt:	01/14/2021
Title:	Mononuclear Cell Derived NK Cells

83

Patent #:	11389521	Issue Dt:	07/19/2022	Application #:	16859490	Filing Dt:	04/27/2020
Publication #:	US20200261565	Pub Dt:	08/20/2020
Title:	METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS

84

Patent #:	11684668	Issue Dt:	06/27/2023	Application #:	16883263	Filing Dt:	05/26/2020
Publication #:	US20210283245	Pub Dt:	09/16/2021
Title:	REPLICATION-DEFECTIVE ADENOVIRUSES COMPRISING NUCLEIC ACIDS ENCODING SARS-COV-2 S GLYCOPROTEIN AND MODIFIED N PROTEIN COMPRISING AN ENDOSOMAL TARGETING SEQUENCE

85

Patent #:	10885173	Issue Dt:	01/05/2021	Application #:	16891364	Filing Dt:	06/03/2020
Publication #:	US20200387591	Pub Dt:	12/10/2020
Title:	CONTENT AUTHENTICATION AND VALIDATION VIA MULTI-FACTOR DIGITAL TOKENS, SYSTEMS, AND METHODS

86

Patent #:	NONE	Issue Dt:		Application #:	16893213	Filing Dt:	06/04/2020
Publication #:	US20200392577	Pub Dt:	12/17/2020
Title:	Biological Deposit Labeling And Tracking Including Isotope, Rare Earth Metal Or Mitochondria Tags

87

Patent #:	11000550	Issue Dt:	05/11/2021	Application #:	16903882	Filing Dt:	06/17/2020
Publication #:	US20200306312	Pub Dt:	10/01/2020
Title:	GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER

88

Patent #:	11471511	Issue Dt:	10/18/2022	Application #:	16925138	Filing Dt:	07/09/2020
Publication #:	US20210030844	Pub Dt:	02/04/2021
Title:	IL-15-BASED MOLECULES AND METHODS OF USE THEREOF

89

Patent #:	11364291	Issue Dt:	06/21/2022	Application #:	16932331	Filing Dt:	07/17/2020
Title:	BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER

90

Patent #:	NONE	Issue Dt:		Application #:	16934606	Filing Dt:	07/21/2020
Publication #:	US20200376033	Pub Dt:	12/03/2020
Title:	ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS

91

Patent #:	NONE	Issue Dt:	06/11/2024	Application #:	16935987	Filing Dt:	07/22/2020
Publication #:	US20220025402	Pub Dt:	01/27/2022
Title:	Electroporation With Active Compensation

92

Patent #:	11753625	Issue Dt:	09/12/2023	Application #:	16937370	Filing Dt:	07/23/2020
Publication #:	US20200347351	Pub Dt:	11/05/2020
Title:	MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC

93

Patent #:	11788059	Issue Dt:	10/17/2023	Application #:	16940018	Filing Dt:	07/27/2020
Publication #:	US20210054337	Pub Dt:	02/25/2021
Title:	MODIFIED NK-92 CELLS FOR TREATING CANCER

94

Patent #:	NONE	Issue Dt:	05/28/2024	Application #:	16953879	Filing Dt:	11/20/2020
Publication #:	US20210145879	Pub Dt:	05/20/2021
Title:	Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment

95

Patent #:	11573230	Issue Dt:	02/07/2023	Application #:	16964325	Filing Dt:	07/23/2020
Publication #:	US20210041438	Pub Dt:	02/11/2021
Title:	RAPID VERIFICATION OF VIRUS PARTICLE PRODUCTION FOR A PERSONALIZED VACCINE

96

Patent #:	NONE	Issue Dt:		Application #:	16964962	Filing Dt:	07/24/2020
Publication #:	US20210040451	Pub Dt:	02/11/2021
Title:	USE OF 5% HUMAN ALBUMIN IN WASH AND HARVEST MEDIA

97

Patent #:	11813292	Issue Dt:	11/14/2023	Application #:	16966868	Filing Dt:	07/31/2020
Publication #:	US20210038645	Pub Dt:	02/11/2021
Title:	USE OF CD33CAR MODIFIED HIGH AFFINITY NK CELLS (T-HANK) TO REDUCE MYELOID-DERIVED SUPPRESSOR CELLS SUPPRESSOR ACTIVITY (OR REDUCE NEGATIVE IMPACT ON NK CELL ACTIVITY)

98

Patent #:	11547727	Issue Dt:	01/10/2023	Application #:	16969152	Filing Dt:	08/11/2020
Publication #:	US20210260116	Pub Dt:	08/26/2021
Title:	Chimeric Antigen Receptor-Modified NK-92 Cells

99

Patent #:	NONE	Issue Dt:		Application #:	16985090	Filing Dt:	08/04/2020
Publication #:	US20210040175	Pub Dt:	02/11/2021
Title:	Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation

100

Patent #:	11941813	Issue Dt:	03/26/2024	Application #:	16996068	Filing Dt:	08/18/2020
Publication #:	US20210056363	Pub Dt:	02/25/2021
Title:	Systems And Methods For Performing Segmentation Based On Tensor Inputs

Assignors

1

IMMUNITYBIO, INC.

Exec Dt:

12/29/2023

2

Exec Dt:

12/29/2023

3

RECEPTOME, INC.

Exec Dt:

12/29/2023

4

VBC HOLDINGS LLC

Exec Dt:

12/29/2023

5

ALTOR BIOSCIENCE, LLC

Exec Dt:

12/29/2023

6

ETUBICS CORPORATION

Exec Dt:

12/29/2023

7

Exec Dt:

12/29/2023

Assignee

1

INFINITY SA LLC, AS PURCHASER AGENT

C/O OBERLAND CAPITAL MANAGEMENT LLC

1700 BROADWAY, 37TH FL

NEW YORK, NEW YORK 10019

Correspondence name and address
	JENNIFER FITZPATRICK
	C/O COOLEY LLP
	1299 PENNSYLVANIA AVENUE, NW, SUITE 700
	WASHINGTON, DC 20004

Search Results as of: 05/24/2024 05:29 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6

| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT